Taggart Clifford C, Greene Catherine M, Smith Stephen G, Levine Rodney L, McCray Paul B, O'Neill Shane, McElvaney Noel G
Pulmonary Research Division, Department of Medicine, Royal College of Surgeons in Ireland, Education and Research Center, Beaumont Hospital, Dublin, Ireland.
J Immunol. 2003 Jul 15;171(2):931-7. doi: 10.4049/jimmunol.171.2.931.
beta-Defensins are antimicrobial peptides that contribute to the innate immune responses of eukaryotes. At least three defensins, human beta-defensins 1, 2, and 3 (HBD-1, -2, and -3), are produced by epithelial cells lining the respiratory tract and are active toward Gram-positive (HBD-3) and Gram-negative (HBD-1, -2, and -3) bacteria. It has been postulated that the antimicrobial activity of defensins is compromised by changes in airway surface liquid composition in lungs of patients with cystic fibrosis (CF), therefore contributing to the bacterial colonization of the lung by Pseudomonas and other bacteria in CF. In this report we demonstrate that HBD-2 and HBD-3 are susceptible to degradation and inactivation by the cysteine proteases cathepsins B, L, and S. In addition, we show that all three cathepsins are present and active in CF bronchoalveolar lavage. Incubation of HBD-2 and -3 with CF bronchoalveolar lavage leads to their degradation, which can be completely (HBD-2) or partially (HBD-3) inhibited by a cathepsin inhibitor. These results suggest that beta-defensins are susceptible to degradation and inactivation by host proteases, which may be important in the regulation of beta-defensin activity. In chronic lung diseases associated with infection, overexpression of cathepsins may lead to increased degradation of HBD-2 and -3, thereby favoring bacterial infection and colonization.
β-防御素是有助于真核生物先天免疫反应的抗菌肽。至少三种防御素,即人β-防御素1、2和3(HBD-1、-2和-3),由呼吸道内衬的上皮细胞产生,对革兰氏阳性菌(HBD-3)和革兰氏阴性菌(HBD-1、-2和-3)具有活性。据推测,囊性纤维化(CF)患者肺部气道表面液体成分的变化会损害防御素的抗菌活性,从而导致CF患者肺部被铜绿假单胞菌和其他细菌定植。在本报告中,我们证明HBD-2和HBD-3易被半胱氨酸蛋白酶组织蛋白酶B、L和S降解和失活。此外,我们表明这三种组织蛋白酶在CF支气管肺泡灌洗中均存在且具有活性。将HBD-2和-3与CF支气管肺泡灌洗孵育会导致它们降解,组织蛋白酶抑制剂可完全抑制(HBD-2)或部分抑制(HBD-3)这种降解。这些结果表明,β-防御素易被宿主蛋白酶降解和失活,这可能在β-防御素活性的调节中起重要作用。在与感染相关的慢性肺部疾病中,组织蛋白酶的过度表达可能导致HBD-2和-3的降解增加,从而有利于细菌感染和定植。